Company Name
Jiangxi Aifeimu Technology Co., Ltd.
Year of Establishment
2004
Annual Turnover(USD)
2,000,000 to 2,999,999
Company Introduction
Jiangxi Aifeimu Technology Co.,Ltd with Dapoxetine series, Atorvastatin Calcium, Fluvastatin Sodium, Rosuvastatin Calcium, Pitavastatin Calcium, dapagliflozin, empagliflozin and their intermediates as main products. Based on top technologies, Aifeimu has adopted advanced quality control system from overseas to put strict control on material purchase, production and sales. Advanced testing instruments and perfect testing methods are also employed to ensure the products are in accordance with the USP/EP standards.
Main Competitive Advantages
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing,Buyers´ Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.afmpharm.com
Other Competitive Advantages